Repository logo
Communities & Collections
Research Outputs
Fundings & Projects
People
Statistics
User Manual
Have you forgotten your password?
  1. Home
  2. Faculty of Medicine
  3. Faculty of Medicine: Journal Articles
  4. 18F-FDG PET/CT IN DIFFERENTIATING EQUIVOCAL CT LESIONS IN PATIENTS WITH COLORECTAL CANCER
Details

18F-FDG PET/CT IN DIFFERENTIATING EQUIVOCAL CT LESIONS IN PATIENTS WITH COLORECTAL CANCER

Journal
Journal of Morphological Sciences
Date Issued
2022-05-22
Author(s)
Beshliev, Simon
DOI
10.55302/jms2251001s
Abstract
Imaging is vital in the follow-up strategy of patients with colorectal cancer. Computed tomography is widely accepted as a method of choice, but further work up is required when equivocal findings are present. The objective of this study was to investigate the potential of positron emission tomography (PET)/computed tomography (CT) as a problem-solving tool of dubious CT findings in patients with colorectal cancer (CRC) in the follow-up period. This was a retrospective review of thirty-two patients referred for 18F-fluorodeoxyglucose (FDG) PET/CT imaging due to suspicion of recurrent disease solely based on CT exam. The diagnosis of a malignancy lesion was based on intensity of the lesion, location, shape, size, as well as CT findings. There was a follow-up period of at least six months after the PET/CT examination. The most common site of detected lesions that could not be characterized by CT were the lungs (13/32; 40.5%), followed by liver (8/32, 25%) and lymph nodes (5/32, 15.6%). Additionally, lesions were reported at adrenal gland, spleen, peritoneum, ovary and at surgical site. In almost half of the patients (15/32; 46.8%) lesions were detected by PET/CT and characterized as disease recurrence. Metastases at additional site were detected in five patients (6/15, 40%). In the follow-up period recurrent disease was detected in two patients (2/32, 6.2%) with negative PET/CT findings. Only one person had a false positive finding. The overall positive and negative predictive value of FDG-PET/CT was 93.3% and 84.6% respectively. PET/CT offers a high overall positive and negative predictive value in distinguishing CRC metastasis. Furthermore, it exceeds CT performance in detecting extrahepatic recurrent disease.
Subjects

PET scan

CT scan

imaging

colorectal cancer

File(s)
Loading...
Thumbnail Image
Name

318-1-1680-2-10-20220512.pdf

Size

237.39 KB

Format

Adobe PDF

Checksum

(MD5):5d9533f71dc172a551c44b3827924760

⠀

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify